Search company, investor...


Founded Year



Unattributed VC | Alive

Total Raised


Last Raised

$21M | 15 yrs ago

About Progentech

Molecular diagnostics device company developing automated instruments for nucleic acid purification (NAP) and nucleic acid testing (NAT). The company's first fully-integrated NAP system, the PGT 328, increases the efficiency and quality of nucleic acid purification using ProGenTech's designed disposable cartridges.

Headquarters Location

5885 Hollis Street Suite 155

Emeryville, California, 94608,

United States


Missing: Progentech's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Progentech's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Progentech Patents

Progentech has filed 1 patent.

patents chart

Application Date

Grant Date


Related Topics




Genetics, Molecular biology, RNA, Intrusion detection systems, Gene expression


Application Date


Grant Date



Related Topics

Genetics, Molecular biology, RNA, Intrusion detection systems, Gene expression



Progentech Frequently Asked Questions (FAQ)

  • When was Progentech founded?

    Progentech was founded in 2005.

  • Where is Progentech's headquarters?

    Progentech's headquarters is located at 5885 Hollis Street, Emeryville.

  • What is Progentech's latest funding round?

    Progentech's latest funding round is Unattributed VC.

  • How much did Progentech raise?

    Progentech raised a total of $21M.

  • Who are the investors of Progentech?

    Investors of Progentech include DT Capital Partners and Bay City Capital.

  • Who are Progentech's competitors?

    Competitors of Progentech include BioMarker Strategies, EndoChoice, Pathwork Diagnostics, HandyLab, Pria Diagnostics and 13 more.

Compare Progentech to Competitors


CyberGene manufactures custom oligos, ChromoQuant QF-PCR kit for In Vitro Diagnostics and performes DNA sequencing

ADNAvance Technologies

Adnavance Technologies Inc is developing enabling technology applications that use the conductivity properties of both normal and novel metallic forms of DNA aimed at large biosensormolecular diagnostics and energy generationmanagement markets


Quadraspec is changing the face of diagnostic medicine. Quadraspec's patented SDI label-free detection technology aims to permit the rapid analysis of up to 100 unique tests on up to 1,000 unique patients per hour. Quadraspec's , multiplex-capable diagnostics platform aims to allow high throughput, label-free, highly sensitive bioassays, and diagnostics.

BioMicro Systems

BioMicro Systems was founded in 2000 to develop and improve microfluidic microarray sample processing. Microarrays are tools used by major pharmaceutical companies and research laboratories to sift through and analyze information contained within a genome. A microarray consists of different nucleic acid probes that are chemically attached to a substrate, which can be a microchip, a glass slide or microsphere-sized beads. In 2003 BioMicro Systems launched the MAUI Hybridization System, a cutting-edge microarray instrument, designed to target the processing bottleneck encountered during the critical hybridization step in gene expression studies.

Gold Standard Diagnostics

Gold Standard Diagnostics (GSD) provides diagnostic solutions that improve lab efficiency and minimize overall costs. Through an extensive product menu, automated instrument platforms, and outstanding customer service, GSD solves real laboratory problems. The result is a seamless laboratory experience achieved through an integrated approach.

Beacon Analytical Systems

Beacon Develops immunodiagnostic kits for environmental & food/feed testing markets

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.